Table 3.
Frequencies of each treatment efficacy improvement.
| Efficacy improvement* | PUSH score | PSST score | ||||
|---|---|---|---|---|---|---|
| Placebo (N = 39) | CH-a (N = 38) | CH-b (N = 35) | Placebo (N = 39) | CH-a (N = 38) | CH-b (N = 35) | |
| Primary (%) | 9.5 | 18.0 | 28.2 | 7.1 | 10.3 | 23.1 |
| Secondary (%) | 11.9 | 28.2 | 43.6 | 11.9 | 38.5 | 51.3 |
| Primary + secondary (%) | 21.4 | 46.2 | 71.8 | 19.0 | 48.8 | 74.4 |
*The primary treatment efficacy improvement was a reduction in the PUSH score of ≥5 points and a reduction in the PSST score of ≥10 points between the baseline and week 16.
The secondary treatment efficacy improvement was a reduction in the PUSH score of 3–4 points and a reduction in the PSST score of 5–9 points between the baseline and week 16.